Skip to main content
Top

Cancer Causes & Control

Issue 3/2005

Content (14 Articles)

An analysis of risk factors for cutaneous melanoma by anatomical site (Australia)

Victor Siskind, David C. Whiteman, Joanne F. Aitken, Nicholas G. Martin, Adèle C. Green

Hereditary colorectal cancer syndromes

Lisa L. Strate, Sapna Syngal

Early life events and later risk of colorectal cancer: age-period-cohort modelling in the Nordic countries and Estonia

E. Svensson, B. Møller, S. Tretli, L. Barlow, G. Engholm, E. Pukkala, M. Rahu, L. Tryggvadóttir

Dietary intakes of fruit, vegetables, and fiber, and risk of colorectal cancer in a prospective cohort of women (United States)

Jennifer Lin, Shumin M. Zhang, Nancy R. Cook, Kathryn M. Rexrode, Simin Liu, JoAnn E. Manson, I-Min Lee, Julie E. Buring

Are risk factors for breast cancer associated with follow-up procedures in diverse women with abnormal mammography?

Teresa C. Juarbe, Celia Patricia Kaplan, Carol P. Somkin, Rena Pasick, Ginny Gildengorin, Eliseo J. Pérez-Stable

Plasma insulin-like growth factor-1 and binding protein-3 and subsequent risk of prostate cancer in the PSA era

Elizabeth A. Platz, Michael N. Pollak, Michael F. Leitzmann, Meir J. Stampfer, Walter C. Willett, Edward Giovannucci

Sexually transmitted diseases and other urogenital conditions as risk factors for prostate cancer: a case–control study in Wayne County, Michigan

Divya A. Patel, Cathryn H. Bock, Kendra Schwartz, Angela S. Wenzlaff, Raymond Y. Demers, Richard K. Severson

Alcohol drinking and risk of localized versus advanced and sporadic versus familial prostate cancer in Sweden

Ellen T. Chang, Maria Hedelin, Hans-Olov Adami, Henrik Grönberg, Katarina A. Bälter

Fertility patterns prior to testicular cancer diagnosis

Julie A. Baker, Germaine M. Buck, John E. Vena, Kirsten B. Moysich

Regular use of aspirin or acetaminophen and risk of non-Hodgkin lymphoma

Julie A. Baker, Joli R. Weiss, Myron S. Czuczman, Ravi J. Menezes, Christine B. Ambrosone, Kirsten B. Moysich

Cancer incidence patterns among adolescents and young adults in the United States

Xiaocheng Wu, Frank D. Groves, Colleen C. McLaughlin, Ahmedin Jemal, Jim Martin, Vivien W. Chen

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine